---
title: "H.C. Wainwright Keeps Their Buy Rating on Bright Minds Biosciences (DRUG)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290878668.md"
description: "H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Bright Minds Biosciences (DRUG) with a $145 price target. Trucchio, a 5-star analyst in the Healthcare sector, maintains this view alongside an overall Strong Buy consensus for the stock, which has an average price target of $164.26."
datetime: "2026-06-25T20:45:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290878668.md)
  - [en](https://longbridge.com/en/news/290878668.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290878668.md)
---

# H.C. Wainwright Keeps Their Buy Rating on Bright Minds Biosciences (DRUG)

In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Bright Minds Biosciences, with a price target of $145.00.

### TipRanks' Prime Week Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

According to TipRanks, Trucchio is a 5-star analyst with an average return of 30.6% and a 55.08% success rate. Trucchio covers the Healthcare sector, focusing on stocks such as Arrowhead Pharmaceuticals, Aligos Therapeutics, and Silence Therapeutics.

Currently, the analyst consensus on Bright Minds Biosciences is a Strong Buy with an average price target of $164.26.

### Related Stocks

- [DRUG.US](https://longbridge.com/en/quote/DRUG.US.md)
- [ARWR.US](https://longbridge.com/en/quote/ARWR.US.md)
- [ALGS.US](https://longbridge.com/en/quote/ALGS.US.md)
- [SLN.US](https://longbridge.com/en/quote/SLN.US.md)

## Related News & Research

- [ADAR1 Capital Management LLC Has $2.47 Million Stock Position in Bright Minds Biosciences Inc. $DRUG](https://longbridge.com/en/news/294165780.md)
- [How investors can navigate the healthcare sector](https://longbridge.com/en/news/293960711.md)
- [Truist Financial Reaffirms Their Buy Rating on NewAmsterdam Pharma Company (NAMS)](https://longbridge.com/en/news/293930009.md)
- [Goldman Sachs Reaffirms Their Buy Rating on Amneal Pharmaceuticals (AMRX)](https://longbridge.com/en/news/293926120.md)
- [Public Employees Retirement System of Ohio Lowers Stock Holdings in TransUnion $TRU](https://longbridge.com/en/news/294483096.md)